Symbiosis Pharmaceutical Services Limited
Private Limited Company · Stirling
ActiveUnited KingdomIncorporated 2010Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
SC373596- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2010-02-24
- Jurisdiction
- —
- Registered office
- UNIT 10, SCION HOUSE, STIRLING, FK9 4NF
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsDevelopment of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical TrialsInnovate UK · Collaborative R&D · 2018-11-01 – 2021-10-31 · with 2 other participants£253,447awarded
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical Trials
Innovate UK · Collaborative R&D · 2018-11-01 – 2021-10-31 · with 2 other participants
£253,447
awarded
Symbiosis Pharmaceutical Services Limited£253,447
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical TrialsISCF · Collaborative R&D · 2018-11-01 – 2021-10-30 · with 2 other participants£949,548whole project
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical Trials
ISCF · Collaborative R&D · 2018-11-01 – 2021-10-30 · with 2 other participants
£949,548
whole project
Freeline Therapeutics LimitedleadCell Therapy Catapult LimitedSymbiosis Pharmaceutical Services Limited
Capacity Expansion & Simplification of Supply chains for Viral Vector manufacture in the UKInnovate UK · Collaborative R&D · 2017-12-01 – 2019-03-31 · with 1 other participant£1,034,096awarded
Capacity Expansion & Simplification of Supply chains for Viral Vector manufacture in the UK
Innovate UK · Collaborative R&D · 2017-12-01 – 2019-03-31 · with 1 other participant
£1,034,096
awarded
Symbiosis Pharmaceutical Services Limited£1,034,096
Capacity Expansion & Simplification of Supply chains for Viral Vector manufacture in the UKISCF · Collaborative R&D · 2017-12-01 – 2019-03-31 · with 1 other participant£1,906,751whole project
Capacity Expansion & Simplification of Supply chains for Viral Vector manufacture in the UK
ISCF · Collaborative R&D · 2017-12-01 – 2019-03-31 · with 1 other participant
£1,906,751
whole project
Cobra Biologics LimitedleadSymbiosis Pharmaceutical Services Limited
Development and implementation of a next-generation commercial gene therapy manufacturing platformInnovate UK · Collaborative R&D · with 2 other participants
Development and implementation of a next-generation commercial gene therapy manufacturing platform
Innovate UK · Collaborative R&D · with 2 other participants